• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体外血管对三类钙通道拮抗剂反应的差异个体发育

Differential ontogeny of in vitro vascular responses to three categories of calcium channel antagonists in rats.

作者信息

Kullama L K, Balaraman V, Claybaugh J R, Ichimura W M, Pichoff B E, Nakamura K T

机构信息

Department of Pediatrics, Kapiolani Medical Center for Women and Children, Honolulu, Hawaii.

出版信息

Pediatr Res. 1991 Mar;29(3):278-81. doi: 10.1203/00006450-199103000-00011.

DOI:10.1203/00006450-199103000-00011
PMID:1851981
Abstract

We examined the ontogeny of relaxation responses to three categories of calcium channel antagonists, represented by verapamil, diltiazem, and nifedipine, for both potential-operated (KCl-mediated) and receptor-operated channels [norepinephrine (NE)-mediated] in rat thoracic aorta. Aortic rings from 2- to 3-d, 1-wk, and 12-wk-old Sprague Dawley rats were mounted in an organ bath, bathed in Krebs' solution, and connected to a force-displacement transducer to measure isometric tension. Endothelium intact vessels at optimal passive force were exposed to a single ED50 of isotonic KCl or NE, equilibrium contraction was measured, then vessels were washed and exposed for 30 min to 1 microM verapamil, 1 microM diltiazem, or 0.1 microM nifedipine, followed by another dose of KCl or NE. Verapamil and diltiazem demonstrated significant (p less than 0.05) age-related increases in effectiveness for blocking KCl-mediated contraction [(% reduction of control contraction +/- SEM) (Verapamil: 2-3 d, 67.7 +/- 4.2; 1 wk, 72.5 +/- 1.8; 12 wk, 89.5 +/- 1.0. Diltiazem: 2-3 d, 64.6 +/- 2.9; 1 wk, 73.5 +/- 3.0; 12 wk, 83.1 +/- 1.8]. Nifedipine was equally effective at all ages: 2-3 d, 85.6 +/- 1.3; 1 wk, 90.0 +/- 1.6; and 12 wk, 91.3 +/- 1.4. Verapamil and diltiazem also showed significant age-related increases in effectiveness for blocking NE-mediated contraction (Verapamil: 2-3 d, 6.2 +/- 3.9; 1 wk, 28.0 +/- 4.8; 12 wk, 44.1 +/- 6.0. Diltiazem: 2-3 d, 8.0 +/- 3.1; 1 wk, 20.5 +/- 3.9; 12 wk, 46.5 +/- 4.8).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了以维拉帕米、地尔硫䓬和硝苯地平为代表的三类钙通道拮抗剂对大鼠胸主动脉中电位门控通道(KCl介导)和受体门控通道(去甲肾上腺素(NE)介导)的舒张反应的个体发生情况。将2至3日龄、1周龄和12周龄的斯普拉格-道利大鼠的主动脉环安装在器官浴槽中,置于克雷布斯溶液中,并连接到力-位移换能器以测量等长张力。在最佳被动张力下,将内皮完整的血管暴露于等渗KCl或NE的单一半数有效剂量(ED50),测量平衡收缩,然后冲洗血管并将其暴露于1μM维拉帕米、1μM地尔硫䓬或0.1μM硝苯地平30分钟,随后再给予一剂KCl或NE。维拉帕米和地尔硫䓬在阻断KCl介导的收缩方面显示出与年龄相关的显著(p<0.05)有效性增加[(对照收缩减少的百分比±标准误)(维拉帕米:2至3日龄,67.7±4.2;1周龄,72.5±1.8;12周龄,89.5±1.0。地尔硫䓬:2至3日龄,64.6±2.9;1周龄,73.5±3.0;12周龄,83.1±1.8]。硝苯地平在所有年龄段的效果相同:2至3日龄,85.6±1.3;1周龄,90.0±1.6;12周龄,91.3±1.4。维拉帕米和地尔硫䓬在阻断NE介导的收缩方面也显示出与年龄相关的显著有效性增加(维拉帕米:2至3日龄,6.2±3.9;1周龄,28.0±4.8;12周龄,44.1±6.0。地尔硫䓬:2至3日龄,8.0±3.1;1周龄,20.5±3.9;12周龄,46.5±4.8)。(摘要截断于250字)

相似文献

1
Differential ontogeny of in vitro vascular responses to three categories of calcium channel antagonists in rats.大鼠体外血管对三类钙通道拮抗剂反应的差异个体发育
Pediatr Res. 1991 Mar;29(3):278-81. doi: 10.1203/00006450-199103000-00011.
2
Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.地尔硫䓬、硝苯地平及维拉帕米的变时性、变力性和血管舒张作用。生理反应与膜受体活性的比较研究。
Circ Res. 1983 Feb;52(2 Pt 2):I29-39.
3
Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.结构新颖的抗高血压化合物 McN-5691 是一种血管平滑肌中的钙通道阻滞剂。
J Pharmacol Exp Ther. 1991 Jan;256(1):279-88.
4
Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contraction.慢通道钙阻滞剂可减弱复氧介导的血管收缩,但增强缺氧介导的血管收缩。
J Cardiovasc Pharmacol. 1992 May;19(5):701-8.
5
Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.赛庚啶在离体心血管制剂中的钙通道阻滞活性。
J Pharmacol Exp Ther. 1984 Jul;230(1):103-9.
6
Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.地尔硫䓬、尼卡地平、硝苯地平和维拉帕米在无钙培养基中对去甲肾上腺素诱导的犬隐静脉收缩的抑制作用。
Res Commun Chem Pathol Pharmacol. 1994 Mar;83(3):255-69.
7
SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.SR 33557,一种新型钙通道阻滞剂。I. 体外分离组织研究。
J Pharmacol Exp Ther. 1990 Nov;255(2):593-9.
8
Verapamil, diltiazem and nifedipine inhibit vascular responses to noradrenaline, acetylcholine and 5-hydroxytryptamine in human saphenous vein.维拉帕米、地尔硫䓬和硝苯地平可抑制人隐静脉对去甲肾上腺素、乙酰胆碱和5-羟色胺的血管反应。
Pharmacol Res Commun. 1986 Dec;18(12):1123-38. doi: 10.1016/0031-6989(86)90028-7.
9
Effects of calcium antagonists on K(+)-induced contraction in isolated aorta from diabetic and age-matched control rats.钙拮抗剂对糖尿病大鼠和年龄匹配的对照大鼠离体主动脉中钾离子诱导收缩的影响。
Pharmacology. 1993 Apr;46(4):193-7. doi: 10.1159/000139045.
10
Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.自发性高血压大鼠在钙通道阻滞剂给药和停药后的快速大动脉重构。
Eur J Pharmacol. 2009 Oct 1;619(1-3):85-91. doi: 10.1016/j.ejphar.2009.08.003. Epub 2009 Aug 14.